125
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Diagnosis and Management of Insect Allergy: Barriers and Facilitators in the United States

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1773-1781 | Received 01 Oct 2022, Accepted 05 Dec 2022, Published online: 15 Dec 2022

References

  • Golden DB, Demain J, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118:28–54. doi:10.1016/j.anai.2016.10.031
  • Marshall GD; American Academy of Allergy Association, Immunology Workforce Committee. The status of US allergy/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee. J Allergy Clin Immunol. 2007;119:802–807. doi:10.1016/j.jaci.2007.01.040
  • Malick A, Meadows JA. Allergy and immunology physician workforce: where do we stand today? Ann Allergy Asthma Immunol. 2021;127:522–523. doi:10.1016/j.anai.2021.06.008
  • de Asis ML. The future physician workforce: an allergy-immunology specialist perspective. Ann Allergy Asthma Immunol. 1999;83:99–103. doi:10.1016/S1081-1206(10)62619-1
  • Accreditation Council for Graduate Medical Education. ACGME program requirements for graduate medical education in allergy and immunology. 2022.
  • Accreditation Council for Graduate Medical Education. Case log procedures for allergy and immunology programs. 2019.
  • Li JT, Stoll DA, Smith JE, Lin JJ, Swing SR. Graduates’ perceptions of their clinical competencies in allergy and immunology: results of a survey. Acad Med. 2003;78:933–938. doi:10.1097/00001888-200309000-00021
  • Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;47:373–380. doi:10.1016/j.annemergmed.2006.01.018
  • Zanotti R, Lombardo C, Passalacqua G, et al. Clonal mast cell disorders in patients with severe hymenoptera venom allergy and normal serum tryptase levels. J Allergy Clin Immunol. 2015;136:135–139. doi:10.1016/j.jaci.2014.11.035
  • Rosloff DA, Patel K, Feustel PJ, Celestin J. Criteria positive and criteria negative anaphylaxis, with a focus on undifferentiated somatoform idiopathic anaphylaxis: a review and case series. Allergy Asthma Proc. 2020;41:436–441. doi:10.2500/aap.2020.41.200076
  • Choy AC, Patterson R, Patterson DR, et al. Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol. 1995;96:893–900. doi:10.1016/S0091-6749(95)70225-3
  • Mayer ML. Disparities in geographic access to pediatric subspecialty care. Matern Child Health J. 2008;12:624–632. doi:10.1007/s10995-007-0275-3
  • Turner A, Ricketts T, Leslie LK. Comparison of number and geographic distribution of pediatric subspecialists and patient proximity to specialized care in the US between 2003 and 2019. JAMA Pediatr. 2020;174:852–860. doi:10.1001/jamapediatrics.2020.1124
  • Perez-Pimiento A, Prieto-Lastra L, Rodriguez-Cabreros M, Reano-Martos M, Garcia-Cubero A, Garcia-Loria J. Work-related anaphylaxis to wasp sting. Occup Med. 2007;57:602–604. doi:10.1093/occmed/kqm054
  • Grigoreas C, Galatas ID, Kiamouris C, Papaioannou D. Insect-venom allergy in Greek adults. Allergy. 1997;52:51–57. doi:10.1111/j.1398-9995.1997.tb02545.x
  • Fernandez J, Blanca M, Soriano V, Sanchez J, Juarez C. Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin Exp Allergy. 1999;29:1069–1074. doi:10.1046/j.1365-2222.1999.00614.x
  • Brown SG, Franks RW, Baldo BA, Heddle RJ. Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania. J Allergy Clin Immunol. 2003;111:187–192. doi:10.1067/mai.2003.48
  • Kew KM, Cates CJ. Remote versus face-to-face check-ups for asthma. Cochrane Database Syst Rev. 2016;4:CD011715. doi:10.1002/14651858.CD011715.pub2
  • Portnoy JM, Waller M, De Lurgio S, Dinakar C. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016;117:241–245. doi:10.1016/j.anai.2016.07.012
  • Perry TT, Halterman JS, Brown RH, et al. Results of an asthma education program delivered via telemedicine in rural schools. Ann Allergy Asthma Immunol. 2018;120:401–408. doi:10.1016/j.anai.2018.02.013
  • Zhao J, Zhai YK, Zhu WJ, Sun DX. Effectiveness of telemedicine for controlling asthma symptoms: a systematic review and meta-analysis. Telemed J E Health. 2015;21:484–492. doi:10.1089/tmj.2014.0119
  • Culmer N, Smith T, Stager C, et al. Telemedical asthma education and health care outcomes for school-age children: a systematic review. J Allergy Clin Immunol Pract. 2020;8:1908–1918. doi:10.1016/j.jaip.2020.02.005
  • Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P. The effects of telemedicine on asthma control and patients’ quality of life in adults: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7:199–216 e111. doi:10.1016/j.jaip.2018.07.015
  • Bajowala SS, Shih J, Varshney P, Elliott T. The future of telehealth for allergic disease. J Allergy Clin Immunol Pract. 2022;10:2514–2523. doi:10.1016/j.jaip.2022.08.022
  • Ozturk AB, Baccioglu A, Soyer O, Civelek E, Sekerel BE, Bavbek S. Change in allergy practice during the COVID-19 pandemic. Int Arch Allergy Immunol. 2021;182:49–52. doi:10.1159/000512079
  • Goldberg A, Confino-Cohen R. Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol. 1997;100:182–184. doi:10.1016/S0091-6749(97)70222-7
  • Park HJ, Brooks DI, Chavarria CS, Wu RL, Mikita CP, Beakes DE. Combining discordant serum IgE and skin testing improves diagnostic and therapeutic accuracy for hymenoptera venom hypersensitivity immunotherapy. J Allergy Clin Immunol Pract. 2022;10:837–843 e833. doi:10.1016/j.jaip.2021.08.037
  • Tracy JM. Testing for venom allergy: should we change testing order? J Allergy Clin Immunol Pract. 2022;10:844–845. doi:10.1016/j.jaip.2021.12.028
  • Korosec P, Jakob T, Harb H, et al. Worldwide perspectives on venom allergy. World Allergy Organ J. 2019;12:100067. doi:10.1016/j.waojou.2019.100067
  • Golden DB, Bernstein DI, Freeman TM, Tracy JM, Lang DM, Nicklas RA. AAAAI/ACAAI joint venom extract shortage task force report. Ann Allergy Asthma Immunol. 2017;118:283–285. doi:10.1016/j.anai.2017.02.001
  • Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100:S1–148. doi:10.1016/s1081-1206(10)60305-5
  • Kjaer HF, Mortz CG, Bindslev-Jensen C. Does treatment with antidepressants, antipsychotics, or benzodiazepines hamper allergy skin testing? Clin Transl Allergy. 2021;11:e12060. doi:10.1002/clt2.12060
  • Baker TW, Forester JP, Johnson ML, Stolfi A, Stahl MC. The HIT study: hymenoptera identification test--how accurate are people at identifying stinging insects? Ann Allergy Asthma Immunol. 2014;113:267–270. doi:10.1016/j.anai.2014.05.029
  • Javors MA, Zhou W, Maas JW, Han S, Keenan RW. Effects of fire ant venom alkaloids on platelet and neutrophil function. Life Sci. 1993;53:1105–1112. doi:10.1016/0024-3205(93)90546-F
  • Carlson JC, Fox MS. Exposure to species of Vespidae in the urbanized areas of New Orleans, Louisiana. Ann Allergy Asthma Immunol. 2021;127:384–386. doi:10.1016/j.anai.2021.05.014
  • Sturm GJ, Kranzelbinder B, Schuster C, et al. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014;133:1635–1643 e1631. doi:10.1016/j.jaci.2013.10.046
  • Blank S, Bilo MB, Ollert M. Component-resolved diagnostics to direct in venom immunotherapy: important steps towards precision medicine. Clin Exp Allergy. 2018;48:354–364. doi:10.1111/cea.13090
  • Holzweber F, Svehla E, Fellner W, et al. Inhibition of IgE binding to cross-reactive carbohydrate determinants enhances diagnostic selectivity. Allergy. 2013;68:1269–1277. doi:10.1111/all.12229
  • Blank S, Etzold S, Darsow U, et al. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. Hum Vaccin Immunother. 2017;13:2482–2489. doi:10.1080/21645515.2017.1323603
  • Jakob T, Rauber MM, Perez-Riverol A, Spillner E, Blank S. The honeybee venom major allergen Api m 10 (Icarapin) and its role in diagnostics and treatment of hymenoptera venom allergy. Curr Allergy Asthma Rep. 2020;20:48. doi:10.1007/s11882-020-00943-3
  • Blank S, Bazon ML, Grosch J, et al. Antigen 5 allergens of hymenoptera venoms and their role in diagnosis and therapy of venom allergy. Curr Allergy Asthma Rep. 2020;20:58. doi:10.1007/s11882-020-00954-0
  • Kosnik M, Korosec P, Silar M, Music E, Erzen R. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting. Croat Med J. 2002;43:25–27.
  • Campbell RL, Luke A, Weaver AL, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol. 2008;101:631–636. doi:10.1016/S1081-1206(10)60227-X
  • Arga M, Topal E, Yilmaz S, Erdemli PC, Bicakci K, Bakirtas A. Healthcare workers` knowledge level regarding anaphylaxis and usage of epinephrine auto-injectors. Turk J Pediatr. 2021;63:372–383. doi:10.24953/turkjped.2021.03.004
  • Amirzadeh A, Verma P, Lee S, Klaustermeyer W. Epinephrine auto-injector use and demographics in a Veterans Administration population. Allergy Asthma Proc. 2010;31:304–307. doi:10.2500/aap.2010.31.3351
  • Warren CM, Zaslavsky JM, Kan K, Spergel JM, Gupta RS. Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults. Ann Allergy Asthma Immunol. 2018;121:479–489 e472. doi:10.1016/j.anai.2018.06.010
  • Szychlinski C, Schmeissing KA, Fuleihan Z, et al. Food allergy emergency preparedness in Illinois schools: rural disparity in guideline implementation. J Allergy Clin Immunol Pract. 2015;3:805–807 e808. doi:10.1016/j.jaip.2015.04.017
  • Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–264. doi:10.1016/0091-6749(73)90044-4
  • Neupert KB, Huntwork MP, Udemgba C, Carlson JC. Implementation of stock epinephrine in chartered versus unchartered public-school districts. J Sch Health. 2022;92:812–814. doi:10.1111/josh.13159
  • Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4:285–290. doi:10.1097/01.all.0000136762.89313.0b
  • Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–1150. doi:10.1046/j.1365-2222.2000.00864.x
  • Muller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol. 1992;89:529–535. doi:10.1016/0091-6749(92)90319-W
  • Patel AM, Wang V, Philipp A, Yusin JS. Underuse of allergy services for patients having systemic reactions to Hymenoptera venom stings. Ann Allergy Asthma Immunol. 2017;118:366–367. doi:10.1016/j.anai.2016.11.025
  • Birnbaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy. 1993;23:226–230. doi:10.1111/j.1365-2222.1993.tb00886.x
  • Teachout J, Vandegrift S, Schafer C, Uekert S, Gell K. Improved patient adherence to subcutaneous allergen immunotherapy using a modified rush immunotherapy protocol. Ann Allergy Asthma Immunol. 2019;122:347–349. doi:10.1016/j.anai.2018.10.005
  • Lee JH, Lee SH, Ban GY, et al. Factors associated with adherence to allergen specific subcutaneous immunotherapy. Yonsei Med J. 2019;60:570–577. doi:10.3349/ymj.2019.60.6.570
  • Neaves BI, Adams KE, White KM, Stokes SC, Sacha J, Quinn JM. Long-term adherence to imported fire ant subcutaneous immunotherapy. Ann Allergy Asthma Immunol. 2022. doi:10.1016/j.anai.2022.09.020
  • Berchtold E, Maibach R, Muller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy. 1992;22:59–65. doi:10.1111/j.1365-2222.1992.tb00115.x
  • Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy. 2000;55:484–488. doi:10.1034/j.1398-9995.2000.00520.x
  • Arseneau AM, Nesselroad TD, Dietrich JJ, et al. A 1-day imported fire ant rush immunotherapy schedule with and without premedication. Ann Allergy Asthma Immunol. 2013;111:562–566. doi:10.1016/j.anai.2013.08.021
  • Park M, Kapoor S, Yi J, Hura N, Lin S. Systematic review of real-world persistence and adherence in subcutaneous allergen immunotherapy. Int Forum Allergy Rhinol. 2022. doi:10.1002/alr.23078
  • Kiel MA, Roder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Molken MP. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353–360 e352. doi:10.1016/j.jaci.2013.03.013
  • Koca Kalkan I, Ates H, Aksu K, et al. Real-life adherence to subcutaneous immunotherapy: what has changed in the era of the COVID-19 pandemic. World Allergy Organ J. 2021;14:100558. doi:10.1016/j.waojou.2021.100558
  • Rueff F, Wolf H, Schnitker J, Ring J, Przybilla B. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy. 2004;59:589–595. doi:10.1111/j.1398-9995.2004.00505.x
  • Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181:315–323. doi:10.1164/rccm.200906-0896OC
  • Stokes SC, Quinn JM, Sacha JJ, White KM. Adherence to imported fire ant subcutaneous immunotherapy. Ann Allergy Asthma Immunol. 2013;110:165–167. doi:10.1016/j.anai.2012.11.010
  • Gadde J, Sobotka A, Valentine M, Lichtenstein L, Golden D. Intervals of 6 and 8 weeks in maintenance venom immunotherapy (MVIT). Ann Allergy. 1985;54:348.
  • Cavallucci E, Ramondo S, Renzetti A, et al. Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence. J Investig Allergol Clin Immunol. 2010;20:63–68.
  • Lerch E, Muller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol. 1998;101:606–612. doi:10.1016/S0091-6749(98)70167-8
  • Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol. 1991;88:339–348. doi:10.1016/0091-6749(91)90095-6
  • Carneiro-Leao L, Amaral L, Coimbra A. Reasons for Declining Venom Immunotherapy. Acta Med Port. 2018;31:618–623. doi:10.20344/amp.9695
  • Meadows JA, Golden DBK, Tracy J, Reyes EG, Sublett J. Venom shortages: what’s an allergist to do? Part 1, the issues. Ann Allergy Asthma Immunol. 2019;123:9–10. doi:10.1016/j.anai.2019.03.006
  • Meadows JA, Golden DBK, Tracy J, Reyes EG, Sublett J. Venom shortages: what’s an allergist to do? Part two: potential solutions. Ann Allergy Asthma Immunol. 2019;123:131–132. doi:10.1016/j.anai.2019.03.001